3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
2
Sarcoma
1
NET
1
Breast
1
Conditions
Neuroendocrine Tumors
26
Sarcoma
4
Carcinoma, Neuroendocrine
4
Prostatic Neoplasms
3
Pheochromocytoma
3
Paraganglioma
3
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma
3
Breast Neoplasms
3
Adenoma, Islet Cell
3
Thyroid Neoplasms
2
Stomach Neoplasms
2
Neoplasms by Site
2
Neoplasms by Histologic Type
2
Meningioma
2
Melanoma
2
Liver Neoplasms
2
Head and Neck Neoplasms
2
Gastrointestinal Neoplasms
2
Gastro-enteropancreatic neuroendocrine tumor
2
Digestive System Neoplasms
2
Colonic Neoplasms
2
Colonic Diseases
2
Carcinoma, Renal Cell
2
Carcinoid Tumor
2
Adenocarcinoma
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hyperinsulinism
×
NET
×
30 days
×
Clear all
NCT06881992
2026-05-18
Tumor HI
Rezolute
Phase 3
Recruiting
16 enrolled